Amgen AMGN stock has declined 12.6% in the past three months. Investors are increasingly worried about a mix of near-term revenue pressure, patent expirations, obesity-drug competition and uncertainty ...

Eli Lilly and Novo Nordisk continue to spend sizably while advertising their GLP-1s. Outside of the weight-loss wars, Johnson & Johnson reported that its quarterly selling, marketing and ...

Guggenheim trimmed its price target (PT) on Amgen (NASDAQ:AMGN) to $340 from $351 on Monday, May 4, while maintaining a Neutral rating. The revision follows the biotech’s Q1 2026 earnings release and ...

Track Pfizer share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss ...

DENVER — Colorado's first-in-the-nation law that allows a state board to limit prescription drug prices is facing a new legal challenge. The pharmaceutical company Amgen is suing the Colorado ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

A drugmaker whose product could be the first subjected to a price cap in Colorado is suing to throw out the state board that deemed its medication unaffordable. In February, the Colorado Prescription ...

Getting your Trinity Audio player ready... A drugmaker whose product could be the first subjected to a price cap in Colorado is suing to throw out the state board that deemed its medication ...

Amgen’s arthritis blockbuster Enbrel already owns an undesirable spot on the list of 10 drugs eligible for the first round of Medicare pricing negotiations. Now, the company is fighting back against a ...

A state board in Colorado is working to make history by becoming the first in the country to cap the price of a drug it deems unaffordable. Amid an aggressive industry lobbying campaign, Colorado ...

Getting your Trinity Audio player ready... A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions ...